Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

Severe eosinophilic is effectively treated with benralizumab, with especially good outcomes in patients with high BEC and high FeNO.

(NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent ® ...

Objective: To investigate the effect of Mometasone furoate (Elocon Cream) Nasal Spray (MFNS) treatment on hearing secretory Otitis Media (SOM) in younger children. Methods: Seventy-six children with ...

CeraMax contains the active ingredient Natamycin, a biological molecule produced by soil bacteria that prevents soil-borne ...

Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic in Phase 2 development designed to treat cocaine intoxication that has FDA Breakthrough Therapy designation, and its ...

an innovative biologic therapy for asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). This acceptance, announced today, is based on the promising results from the SWIFT and ANCHOR ...

In Japan, the submitted indications are for treatment of severe or refractory bronchial asthma and CRSwNP inadequately controlled with ... interleukin-5 (IL-5), is the first ultra-long-acting biologic ...

Our biological sciences students explore the complexities of life and work to address global challenges in biology. Our faculty advance knowledge in a wide range of disciplines within the biological ...